Literature DB >> 30204889

How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis.

Fabio Midulla1, Raffaella Nenna1, Carolina Scagnolari2, Laura Petrarca1, Antonella Frassanito1, Agnese Viscido2, Serena Arima3, Guido Antonelli2, Alessandra Pierangeli2.   

Abstract

Background: We aimed to study respiratory syncytial virus (RSV) genotype distribution, clinical presentation, and disease severity in infants with bronchiolitis from RSV subtypes and new RSV genotypes.
Methods: We prospectively enrolled previously healthy term infants less than 1 year old hospitalized for bronchiolitis in an Italian university hospital over 12 epidemic seasons. In 312 nasopharyngeal washings positive for RSV, we sequenced the viral genotype and analyzed this according to patient data. Strain-specific RSV loads were quantified for 273 specimens.
Results: From 2005-2006 to 2011-2012, the RSV-A genotype NA1 predominated, and was replaced in 2012 by the novel ON1. All infants infected with RSV subtype B were genotype BA. Stratifying data according to genotypes NA1, ON1, and BA showed that NA1-infected infants were the youngest and had the most severe clinical course. Conversely, BA-infected infants had less severe symptoms and more frequently had eosinophilia and a family history of asthma. Infants with the ON1 genotype had a milder clinical course than those with NA1 and more risk factors for asthma, despite having the highest viral loads.
Conclusion: The disease course in infants hospitalized for acute RSV bronchiolitis may depend on the RSV genotype.

Entities:  

Mesh:

Year:  2019        PMID: 30204889     DOI: 10.1093/infdis/jiy496

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1.

Authors:  Alessandra Pierangeli; Agnese Viscido; Camilla Bitossi; Federica Frasca; Massimo Gentile; Giuseppe Oliveto; Antonella Frassanito; Raffaella Nenna; Fabio Midulla; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2019-09-04       Impact factor: 3.402

Review 2.  Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.

Authors:  Homero San-Juan-Vergara; Mark E Peeples
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-22       Impact factor: 3.479

3.  [Epidemiological characteristics of respiratory syncytial virus in hospitalized children with acute lower respiratory tract infection in Chongqing, China, from 2013 to 2018: an analysis of 2 066 cases].

Authors:  Kang-Yi Ren; Luo Ren; Yu Deng; Xiao-Hong Xie; Na Zang; Jun Xie; Zheng-Xiu Luo; Jian Luo; Zhou Fu; EnMei Liu; Qu-Bei Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

4.  Management of Hospitalized Respiratory Syncytial Virus Bronchiolitis in the Pediatric Ward in Spain: Assessing the Impact of a New Clinical Practice Protocol.

Authors:  Jorgina Vila; Esther Lera; Paula Peremiquel-Trillas; Laia Martínez; Irene Barceló; Cristina Andrés; José Ángel Rodrigo-Pendás; Andrés Antón; Carlos Rodrigo
Journal:  Paediatr Drugs       Date:  2021-12-22       Impact factor: 3.022

Review 5.  The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to individualize pharmacological management?

Authors:  Carlos E Rodríguez-Martínez; Jose A Castro-Rodriguez; Gustavo Nino; Fabio Midulla
Journal:  Paediatr Respir Rev       Date:  2019-04-12       Impact factor: 2.726

6.  Respiratory Syncityal Virus A and B: three bronchiolitis seasons in a third level hospital in Italy.

Authors:  C Ciarlitto; A C Vittucci; L Antilici; C Concato; C Di Camillo; P Zangari; A Villani
Journal:  Ital J Pediatr       Date:  2019-08-28       Impact factor: 2.638

7.  Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017.

Authors:  Madelief Mollers; Céline Barnadas; Eeva K Broberg; Pasi Penttinen; Anne C Teirlinck; Thea K Fischer
Journal:  Euro Surveill       Date:  2019-10

8.  Factors Contributing to Symptom Duration and Viral Reduction in Outpatient Children With Respiratory Syncytial Virus Infection.

Authors:  Takeshi Utsunomiya; Akinobu Hibino; Kiyosu Taniguchi; Takao Nagai; Naruo Saito; Ikumi Tanabe; Takashi Odagiri; Yugo Shobugawa; Akira Kaneko; Reiko Saito
Journal:  Pediatr Infect Dis J       Date:  2020-08       Impact factor: 3.806

9.  Chest Computed Tomography Abnormalities and Their Relationship to the Clinical Manifestation of Respiratory Syncytial Virus Infection in a Genetically Confirmed Outbreak.

Authors:  Daijiro Nabeya; Takeshi Kinjo; Gretchen Lynn Parrott; Sawako Nakachi; Tomoko Yamashiro; Nanae Ikemiyagi; Wakako Arakaki; Hiroaki Masuzaki; Jiro Fujita
Journal:  Intern Med       Date:  2020-01-15       Impact factor: 1.271

10.  Nasal Microbiota in RSV Bronchiolitis.

Authors:  Serena Schippa; Antonella Frassanito; Massimiliano Marazzato; Raffaella Nenna; Laura Petrarca; Bruna Neroni; Giulia Bonfiglio; Francesca Guerrieri; Federica Frasca; Giuseppe Oliveto; Alessandra Pierangeli; Fabio Midulla
Journal:  Microorganisms       Date:  2020-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.